O'Donovan Claire, Alda Martin
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Front Psychiatry. 2020 Jun 11;11:500. doi: 10.3389/fpsyt.2020.00500. eCollection 2020.
This paper focuses on depression that precedes an onset of manifest bipolar disorder as early stage bipolar disorder. First, we review how to pragmatically identify the clinical characteristics of patients presenting with an episode of depression who subsequently go on to develop episodes of mania or hypomania. The existing literature shows a strong consensus: accurate identification of depression with early onset and recurrent course with multiple episodes, subthreshold hypomanic and/or mixed symptoms, and family history of bipolar disorder or completed suicide have been shown by multiple authors as signs pointing to bipolar diagnosis. This contrasts with relatively limited information available to guide management of such "pre-bipolar" (pre-declared bipolar) patients, especially those in the adult age range. Default assumption of unipolar depression at this stage carries significant risk. Antidepressants are still the most common pharmacological treatment used, but clinicians need to be aware of their potential harm. In some patients with unrecognized bipolar depression, antidepressants can not only produce switch to (hypo)mania, but also mixed symptoms, or worsening of depression with an increased risk of suicide. We review pragmatic management strategies in the literature beyond clinical guidelines that can be considered for this at-risk group encompassing the more recent child and adolescent literature. In the future, genetic research could make the early identification of bipolar depression easier by generating informative markers and polygenic risk scores.
本文聚焦于早发性双相情感障碍,即显性双相情感障碍发作之前出现的抑郁发作。首先,我们回顾如何切实地识别那些最初表现为抑郁发作,随后又发展为躁狂或轻躁狂发作的患者的临床特征。现有文献显示出强烈的共识:多位作者已表明,准确识别早发性、具有多次发作的复发性病程、阈下轻躁狂和/或混合症状以及双相情感障碍家族史或自杀身亡史等特征,均指向双相情感障碍的诊断。这与用于指导此类“双相情感障碍前期”(未确诊双相情感障碍)患者管理的信息相对有限形成对比,尤其是成年患者。在此阶段默认诊断为单相抑郁存在重大风险。抗抑郁药仍是最常用的药物治疗方法,但临床医生需要意识到其潜在危害。在一些未被识别的双相抑郁患者中,抗抑郁药不仅会导致转为(轻)躁狂,还会引发混合症状,或使抑郁症状恶化,增加自杀风险。我们回顾了文献中除临床指南之外的切实可行的管理策略,这些策略可用于这一高危群体,包括最新的儿童和青少年文献。未来,基因研究可能通过生成信息性标记和多基因风险评分,使双相抑郁的早期识别更加容易。